Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Blueberries Medical Corp. (C:BBM)

Business Focus: Cannabis Product Retailers

Sector:  Consumer Non-Cyclicals Industry:  Drug Retailers
See Regulatory Filings on SEDAR
Company Contact
Address: 885 West Georgia Street
Suite 2200, HSBC Building
Tel: N/A
IR: See website
Key People
Business Overview
Blueberries Medical Corp. (Blueberries) is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the cultivation and development of medicinal cannabis and related products. The Company is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
Financial Overview
For the three months ended 31 March 2022, Blueberries Medical Corp revenues increased 46% to C$34K. Net loss increased 11% to C$656K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Share based compensation expense (recove increase from C$31K (income) to C$44K (expense), Salary and benefits increase from C$64K to C$138K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $5.83M as of Mar 31, 2022
Annual revenue (TTM): $0.15M as of Mar 31, 2022
EBITDA (TTM): -$1.09M as of Mar 31, 2022
Net annual income (TTM): -$5.21M as of Mar 31, 2022
Free cash flow (TTM): -$1.92M as of Mar 31, 2022
Net Debt Last Fiscal Year: $0.66M as of Mar 31, 2022
Shares outstanding: 163,810,263 as of Mar 31, 2022
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization